Cargando…
Validation of Group B Borderline Resectable Pancreatic Cancer: Retrospective Analysis
BACKGROUND/AIMS: Among borderline resectable pancreatic cancer (BRPC), group B BRPC patients have findings that are suggestive but not diagnostic of metastasis. In this study, we attempted to validate whether group B could truly be categorized as a borderline resectable group. METHODS: We placed the...
Autores principales: | Oh, Tak Geun, Chung, Moon Jae, Bang, Seungmin, Park, Seung Woo, Chung, Jae Bok, Song, Si Young, Seong, Jinsil, Kang, Chang Moo, Lee, Woo Jung, Park, Jeong Youp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Gut and Liver
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164249/ https://www.ncbi.nlm.nih.gov/pubmed/25228978 http://dx.doi.org/10.5009/gnl13264 |
Ejemplares similares
-
Prognostic Factors and Characteristics of Pancreatic Neuroendocrine Tumors: Single Center Experience
por: Oh, Tak Geun, et al.
Publicado: (2012) -
Assessment of the Risk of Colorectal Cancer Survivors Developing a Second Primary Pancreatic Cancer
por: Chung, Joo Won, et al.
Publicado: (2017) -
Clinical Value of Contrast-Enhanced Harmonic Endoscopic Ultrasonography in the Differential Diagnosis of Pancreatic and Gallbladder Masses
por: Leem, Galam, et al.
Publicado: (2018) -
Phase II Trial of Erlotinib Plus Gemcitabine Chemotherapy in Korean Patients with Advanced Pancreatic Cancer and Prognostic Factors for Chemotherapeutic Response
por: Park, Semi, et al.
Publicado: (2013) -
Urgent endoscopic retrograde cholangiopancreatography is not superior to early ERCP in acute biliary pancreatitis with biliary obstruction without cholangitis
por: Lee, Hee Seung, et al.
Publicado: (2018)